← Back to guidelines
Palliative Care14 papers

Frontotemporal degeneration

Last edited: 4/15/2026

Overview

Frontotemporal degeneration (FTD) encompasses a group of disorders characterized by progressive neurodegeneration affecting the frontal and temporal lobes, leading to changes in personality, behavior, language, and motor function 1. Initial symptoms often mimic psychiatric disorders or early-onset Alzheimer's disease, complicating early diagnosis 1.

Diagnosis

  • Clinical Presentation: Profound changes in personality, behavior, language, and movement 1.
  • Subtypes: Behavioral variant FTD and non-fluent primary progressive aphasia are common subtypes 1.
  • Differential Diagnosis: Distinguishing from psychiatric disorders and early-onset Alzheimer's disease is crucial 1.
  • Recommended Tests: Neuropsychological assessments, MRI or CT scans showing atrophy in frontal or temporal lobes, and sometimes genetic testing 1.
  • Management

  • First-Line Treatments: Non-pharmacological interventions such as structured routines, environmental modifications, and caregiver support are essential 1.
  • Pharmacological Interventions: Limited efficacy; antipsychotics (e.g., risperidone, olanzapine) may be considered for severe behavioral disturbances with caution due to increased risk of extrapyramidal side effects 1.
  • Speech Therapy: Beneficial for individuals with language variants of FTD 1.
  • Physical Therapy: Useful for motor symptoms in subtypes involving movement disorders 1.
  • Special Populations

  • Elderly: Management focuses heavily on supportive care and minimizing environmental stressors 1.
  • Comorbidities: Tailored care plans addressing coexisting conditions are necessary, though specific guidelines are not detailed in the abstracts 1.
  • Key Recommendations

  • Prioritize Non-Pharmacological Interventions: Focus on structured care, environmental adjustments, and caregiver support to manage behavioral and cognitive symptoms 1 (Evidence: Strong).
  • Use Caution with Antipsychotics: Consider antipsychotics only for severe behavioral disturbances, weighing risks against benefits 1 (Evidence: Moderate).
  • Tailor Care Plans for Comorbidities: Develop individualized care plans addressing coexisting medical conditions 1 (Evidence: Expert opinion).
  • References

    1 Hall GR, Shapira J, Gallagher M, Denny SS. Managing differences: care of the person with frontotemporal degeneration. Journal of gerontological nursing 2013. link

    Original source

    1. [1]
      Managing differences: care of the person with frontotemporal degeneration.Hall GR, Shapira J, Gallagher M, Denny SS Journal of gerontological nursing (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG